Mabpharm Ltd.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: KYG5780F1046
HKD
0.56
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
China YuHua Education Corp. Ltd.
Greatview Aseptic Packaging Co., Ltd.
China New Higher Education Group Ltd.
FSE Lifestyle Services Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
XJ International Holdings Co., Ltd.
China Conch Environment Protection Holdings Ltd.
Mabpharm Ltd.
Jiangsu Recbio Technology Co., Ltd.
Shimao Services Holdings Ltd.
C-Link Squared Ltd.
Why is Mabpharm Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
  • Poor long term growth as Operating profit has grown by an annual rate 13.61% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 77.78%, its profits have risen by 40.2%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mabpharm Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Mabpharm Ltd.
77.78%
0.45
117.71%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
240.54%
EBIT Growth (5y)
13.61%
EBIT to Interest (avg)
-43.95
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.51
Sales to Capital Employed (avg)
0.35
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
34.86
EV to EBIT
-26.70
EV to EBITDA
-55.16
EV to Capital Employed
14.50
EV to Sales
12.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-54.30%
ROE (Latest)
-145.97%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Mabpharm Ltd.
Net Sales
At HKD 162.45 MM has Grown at 248.54%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely positive

Net Sales (HKD MM)

Operating Cash Flow
Highest at HKD 49.69 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Debtors Turnover Ratio
Highest at 3.52% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales
Highest at HKD 162.45 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit
Highest at HKD 3.72 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin
Highest at 2.29 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at HKD -33.12 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Pre-Tax Profit
At HKD -33.12 MM has Grown at 72.09%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit
Highest at HKD -33.12 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

Net Profit
At HKD -33.12 MM has Grown at 72.09%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS
Highest at HKD -0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Raw Material Cost
Fallen by -628.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Mabpharm Ltd.
Debt-Equity Ratio
Highest at 184.86 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio